Polymeric drug delivery systems for localized cancer chemotherapy

References

• Abe, T., Sakane, M., Ikoma, T., Kobayashi, M., Nakamura, S., Ochiai, N. (2008). Intraosseous delivery of paclitaxel-loaded hydroxyapatite-alginate composite beads delaying paralysis caused by metastatic spine cancer in rats. J Neurosurg Spine. 9:502–10.
   PubMed Web of Science ®Google Scholar
• Al-Ghananeem, A.M., Malkawi, A.H., Muammer, Y.M., Balko, J.M., Black, E.P., Mourad, W., Romond, E. (2009). Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations. AAPS Pharmscitech. 10:410–7.
   PubMed Web of Science ®Google Scholar
• Almond, B., Hadba, A., Freeman, S., Cuevas, B., York, A., Detrisac, C., Goldberg, E.P. (2003). Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Contr Rel. 91:147–55.
   PubMed Web of Science ®Google Scholar
• Anderson, J.M., Shive, M.S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 28:5–24.
   PubMed Web of Science ®Google Scholar
• Armstrong, D.K., Fleming, G.F., Markman, M., Bailey, H.H. (2006). A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer((R))) in recurrent ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 103:391–6.
   PubMed Web of Science ®Google Scholar
• Athanasiou, K.A., Niederauer, G.G., Agrawal, C.M. (1996). Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers. Biomaterials. 17:93–102.
   PubMed Web of Science ®Google Scholar
• Attenello, F.J., Mukherjee, D., Datoo, G., Mcgirt, M.J., Bohan, E., Weingart, J.D., Olivi, A., Quinones-Hinojosa, A., Brem, H. (2008). Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 15:2887–93.
   PubMed Web of Science ®Google Scholar
• Au, J.L.S., Jang, S.H., Zheng, J., Chen, C.T., Song, S., Hu, L., Wientjes,M.G. (2001). Determinants of drug delivery and transport to solid tumors. J Contr Rel. 74:31–46.
   PubMed Web of Science ®Google Scholar
• Azouz, S.M., Walpole, J., Amirifeli, S., Taylor, K.N., Grinstaff, M.W., Colson, Y.L. (2008). Prevention of local tumor growth with paclitaxel-loaded microspheres. J Thorac Cardiovasc Surg. 135:1014–21.
   PubMed Web of Science ®Google Scholar
• Berrada, M., Serreqi, A., Dabbarh, F., Owusu, A., Gupta, A., Lehnert,S. (2005). A novel non-toxic camtothecin formulation for cancer chemotherapy. Biomaterials. 26:2115–20.
   PubMed Web of Science ®Google Scholar
• Berrada, M., Yang, Z., Lehnert, S. (2002). Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments. Int J Radiat Oncol Biol Phys. 54:1550–7.
   PubMed Web of Science ®Google Scholar
• Bouhadir, K.H., Alsberg, E., Mooney, D.J. (2001). Hydrogels for combination delivery of antineoplastic agents. Biomaterials. 22:2625–33.
   PubMed Web of Science ®Google Scholar
• Chourasia, M.K., Jain, S.K. (2004). Polysaccharides for colon targeted drug delivery. Drug Deliv. 11:129–48.
   PubMed Web of Science ®Google Scholar
• D’Souza, R., Mutalik, S., Udupa, N. (2006). In vitro and in vivo preparation evaluations of bleomycin implants and microspheres prepared with DL-poly(lactide-co-glycolide). Drug Dev Ind Pharm. 32:175–84.
   PubMed Web of Science ®Google Scholar
• Davidson, B.S., Izzo, F., Cromeens, D.M., Stephens, L.C., Siddik, Z.H., Curley, S.A. (1995). Collagen matrix cisplatin prevents local tumor growth after margin-positive resection. J Surg Res. 58:618–24.
   PubMed Web of Science ®Google Scholar
• De Souza, R., Zahedi, P., Allen, C., Piquette-Miller, M. (2009). Biocompatibility of injectable chitosan-phospholipid implant systems. Biomaterials. 30:3818–24.
   PubMed Web of Science ®Google Scholar
• Desai, K.G., Mallery, S.R., Schwendeman, S.P. (2008). Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with n-acetylcysteine, a MMP inhibitor. Pharm Res. 25586–597.
   PubMed Web of Science ®Google Scholar
• Dodane, V., Vilivalam, V.D. (1998). Pharmaceutical applications of chitosan. Pharm Sci Technol To. 1:246–53.
   Google Scholar
• Elstad, N.L., Fowers, K.D. (2009). OncoGel (ReGel/paclitaxel)—clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev. 61:785–94.
   PubMed Web of Science ®Google Scholar
• Exner, A.A., Saidel, G.M. (2008). Drug-eluting polymer implants in cancer therapy. Expert Opin Drug Deliv. 5:775–88.
   PubMed Web of Science ®Google Scholar
• Fraser, J.R.E., Laurent, T.C., Laurent, U.B.G. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 242:27–33.
   PubMed Web of Science ®Google Scholar
• Friess, W. (1998). Collagen—biomaterial for drug delivery. Eur J Pharm Biopharm. 45:113–36.
   PubMed Web of Science ®Google Scholar
• Fu, K., Pack, D.W., Klibanov, A.M., Langer, R. (2000). Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 17:100–6.
   PubMed Web of Science ®Google Scholar
• Fulzele, S.V., Satturwar, P.M., Dorle, A.K. (2003). Study of the biodegradation and in vivo biocompatibility of novel biomaterials. Eur J Pharm Sci. 20:53–61.
   PubMed Web of Science ®Google Scholar
• Fung, L.K., Saltzman, W.M. (1997). Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev. 26:209–30.
   PubMed Web of Science ®Google Scholar
• Gasparini, G. (2001). Metronomic scheduling: the future of chemotherapy? Lancet Oncol. 2:733–40.
   PubMed Web of Science ®Google Scholar
• Gelse, K., Poschl, E., Aigner, T. (2003). Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. 55:1531–46.
   PubMed Web of Science ®Google Scholar
• Ghosh, S. (2004). Recent research and development in synthetic polymer-based drug delivery systems. J Chem Res S. 241–6.
   Web of Science ®Google Scholar
• Grant, J., Blicker, M., Piquette-Miller, M., Allen, C. (2005). Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel. J Pharm Sci. 94:1512–27.
   PubMed Web of Science ®Google Scholar
• Grant, J., Lee, H., Soo, P.L., Cho, J., Piquette-Miller, M., Allen, C. (2008). Influence of molecular organization and interactions on drug release for an injectable polymer-lipid blend. Int J Pharm. 360:83–90.
   PubMed Web of Science ®Google Scholar
• Grayson, A.C.R., Voskerician, G., Lynn, A., Anderson, J.M., Cima, M.J., Langer, R. (2004). Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed. 15:1281–304.
   PubMed Web of Science ®Google Scholar
• Han, H.D., Song, C.K., Park, Y.S., Noh, K.H., Kim, J.H., Hwang, T., Kim,T.W., Shin, B.C. (2008). A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm. 350:27–34.
   PubMed Web of Science ®Google Scholar
• Hanes, J., Sills, A., Zhao, Z., Suh, K.W., Tyler, B., Dimeco, F., Brat, D., Choti, M., Leong, K., Pardoll, D., Brem, H. (2001). Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm Res. 18:899–906.
   PubMed Web of Science ®Google Scholar
• Harper, E., Dang, W.B., Lapidus, R.G., Garver, R.I. (1999). Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res. 5:4242–8.
   PubMed Web of Science ®Google Scholar
• Hawe, A., Friess, W. (2007). Formulation development for hydrophobic therapeutic proteins. Pharm Dev Technol. 12:223–37.
   PubMed Web of Science ®Google Scholar
• Hickey, T., Kreutzer, D., Burgess, D.J., Moussy, F. (2002). In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res. 61:180–7.
   PubMed Web of Science ®Google Scholar
• Ho, E.A., Lim Soo, P., Allen, C., Piquette-Miller, M. (2006). Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. J Contr Rel. 117:20–7.
   PubMed Web of Science ®Google Scholar
• Ho, E.A., Vassileva, V., Allen, C., Piquette-Miller, M. (2005). In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. J Contr Rel. 104:181–91.
   PubMed Web of Science ®Google Scholar
• Hsu, W., Lesniak, M., Tyler, B., Brem, H. (2005). Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. J Neuro-Oncol. 74:135–40.
   PubMed Web of Science ®Google Scholar
• Jagur-Grodzinski, J. (2009). Polymers for targeted and/or sustained drug delivery. Polym Adv Technol. 20:595–606.
   Web of Science ®Google Scholar
• Jain, J.P., Chitkara, D., Kumar, N. (2008). Polyanhydrides as localized drug delivery carrier: an update. Expert Opin Drug Del. 5:889–907.
   PubMed Web of Science ®Google Scholar
• Jain, J.P., Modi, S., Domb, A.J., Kumar, N. (2005). Role of polyanhydrides as localized drug carriers. J Contr Rel. 103:541–63.
   PubMed Web of Science ®Google Scholar
• Jang, S.H., Wientjes, M.G., Lu, D., Au, J.L.S. (2003). Drug delivery and transport to solid tumors. Pharm Res. 20:1337–50.
   PubMed Web of Science ®Google Scholar
• Kakinoki, S., Taguchi, T. (2007). Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride. Eur J Pharm Biopharm. 67:676–81.
   PubMed Web of Science ®Google Scholar
• Kean, T., Thanou, M. (2010). Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 62:3–11.
   PubMed Web of Science ®Google Scholar
• Kim, S., Kim, J.H., Jeon, O., Kwon, I.C., Park, K. (2009). Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm. 71:420–30.
   PubMed Web of Science ®Google Scholar
• Konishi, M., Tabata, Y., Kariya, M., Suzuki, A., Mandai, M., Nanbu, K., Takakura, K., Fujii, S. (2003). In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Contr Rel. 92:301–13.
   PubMed Web of Science ®Google Scholar
• Kumar, M.N.V.R. (2000). A review of chitin and chitosan applications. React Funct Polym. 377:76-84..
   Google Scholar
• Kumar, N., Langer, R.S., Domb, A.J. (2002). Polyanhydrides: an overview. Adv Drug Deliv Rev. 54:889–910.
   PubMed Web of Science ®Google Scholar
• Lee, J.S., An, T.K., Chae, G.S., Jeong, J.K., Cho, S.H., Lee, H.B., Khang,G. (2005). Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma. Eur J Pharm Biopharm. 59:169–75.
   PubMed Web of Science ®Google Scholar
• Lee, S.H., Shin, H. (2007). Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 59:339–59.
   PubMed Web of Science ®Google Scholar
• Liao, Y.H., Jones, S.A., Forbes, B., Martin, G.P., Brown, M.B. (2005). Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv. 12:327–42.
   PubMed Web of Science ®Google Scholar
• Liu, Z.H., Jiao, Y.P., Wang, Y.F., Zhou, C.R., Zhang, Z.Y. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev. 60:1650–62.
   PubMed Web of Science ®Google Scholar
• Ma, X., Yu, H. (2006). Global burden of cancer. Yale J Biol Med. 79:85–94.
   PubMedGoogle Scholar
• Maeda, Y., Kimura, Y. (2004). Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr. 134:945–50.
   PubMed Web of Science ®Google Scholar
• Malafaya, P.B., Silva, G.A., Reis, R.L. (2007). Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 59:207–33.
   PubMed Web of Science ®Google Scholar
• Mendez, C.M., Mcclain, C.J., Marsano, L.S. (2005). Albumin therapy in clinical practice. Nutr Clin Pract. 20:314–20.
   PubMedGoogle Scholar
• Minchinton, A.I., Tannock, I.F. (2006). Drug penetration in solid tumours. Nat Rev Cancer. 6:583–92.
   PubMed Web of Science ®Google Scholar
• Mourya, V.K., Inamdar, N.N. (2008). Chitosan-modifications and applications: opportunities galore. React Funct Polym. 68:1013–51.
   Web of Science ®Google Scholar
• Muzzarelli, R.A.A. (1993). Biochemical significance of exogenous chitins and chitosans in animals and patients. Carbohydr Polym. 20:7–16.
   Web of Science ®Google Scholar
• Nair, L.S., Laurencin, C.T. (2007). Biodegradable polymers as biomaterials. Prog Polym Sci. 32:762–98.
   Web of Science ®Google Scholar
• Nezhadi, S.H., Choong, P.F.M., Lotfipour, F., Dass, C.R. (2009). Gelatin-based delivery systems for cancer gene therapy. J Drug Target. 17:731–8.
   PubMed Web of Science ®Google Scholar
• Obara, K., Ishiharab, M., Ozekia, Y., Ishizukaa, T., Hayashib, T., Nakamuraa, S., Saitod, Y., Yurad, T., Matsuib, T., Hattorib, H., Takaseb, B., Ishiharac, M., Kikuchib, M., Maeharaa, T. (2005). Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Contr Rel. 110:79–89.
   PubMed Web of Science ®Google Scholar
• Olsen, D., Yang, C., Bodo, M., Chang, R., Leigh, S., Baez, J., Carmichael,D., Perala, M., Hamalainen, E., Jarvinen, M., Polarek, J. (2003). Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev. 55:1547–67.
   PubMed Web of Science ®Google Scholar
• Park, H., Park, K. (1996). Biocompatibility issues of implantable drug delivery systems. Pharm Res. 13:1770–6.
   PubMed Web of Science ®Google Scholar
• Patil, G.V. (2003). Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res. 58:219–47.
   Web of Science ®Google Scholar
• Pillai, O., Panchagnula, R. (2001). Polymers in drug delivery. Curr Opin Chem Biol. 5:447–51.
   PubMed Web of Science ®Google Scholar
• Qin, C.Q., Du, Y.M., Xiao, L., Li, Z., Gao, X.H. (2002). Enzymic preparation of water-soluble chitosan and their antitumor activity. Int J Biol Macromol. 31:111–7.
   PubMed Web of Science ®Google Scholar
• Ranganath, S.H., Wang, C. (2008). Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials. 29:2996–3003.
   PubMed Web of Science ®Google Scholar
• Read, T.A., Farhadi, M., Bjerkvig, R., Olsen, B.R., Rokstad, A.M., Huszthy, P.C., Vajkoczy, P. (2001). Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. Cancer Res. 61:6830–7.
   PubMed Web of Science ®Google Scholar
• Rhines, L.D., Sampath, P., Dimeco, F., Lawson, H.C., Tyler, B., Hanes, J., Olivi, A., Brem, H. (2002). Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Neurosurgery. 52:872–80.
   Web of Science ®Google Scholar
• Rihova, B. (1996). Biocompatibility of biomaterials: hemocompatibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv Drug Deliv Rev. 21:157–76.
   Web of Science ®Google Scholar
• Ruel-Gariepy, E., Shive, M., Bichara, A., Berrada, M., Le Garrec, D., Chenite, A., Leroux, J.C. (2004). A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm. 57:53–63.
   PubMed Web of Science ®Google Scholar
• Rugo, H.S. (2008). New treatments for metastatic breast cancer: mechanisms of action of nanoparticle albumin-bound taxanes. Community Oncol. 5:8–12.
   Google Scholar
• Sawyer, A.J., Piepmeier, J.M., Saltzman, W.M. (2006). New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med. 79:141–52.
   PubMedGoogle Scholar
• Scharovsky, O.G., Mainetti, L.E., Rozados, V.R. (2009). Metronomic chemotherapy: changing the paradigm that more is better. Curr Oncol. 16:91–99.
   Web of Science ®Google Scholar
• Shikani, A.H., Domb, A.J. (2000). Polymer chemotherapy for head and neck cancer. The Laryngoscope. 110:907–17.
   PubMed Web of Science ®Google Scholar
• Shilpa, A., Agrawal, S.S., Ray, A.R. (2003). Controlled delivery of drugs from alginate matrix. J Macromol Sci-Pol R. 43:187–221.
   Google Scholar
• Sinha, V.R., Kumria, R. (2001). Polysaccharides in colon-specific drug delivery. Int J Pharm. 224:19–38.
   PubMed Web of Science ®Google Scholar
• Storm, P.B., Moriarity, J.L., Tyler, B., Burger, P.C., Brem, H., Weingart,J. (2002). Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy. J Neuro-Oncol. 56:209–17.
   PubMed Web of Science ®Google Scholar
• Stuart, K., Stokes, K., Jenkins, R., Trey, C., Clouse, M. (1993). Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 72:3202–9.
   PubMed Web of Science ®Google Scholar
• Ta, H.T., Dass, C.R., Larson, I., Choong, P.F.M., Dunstan, D.E. (2009). A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma. Biomaterials. 30:3605–13.
   PubMed Web of Science ®Google Scholar
• Taylor, M.S., Daniels, A.U., Andriano, K.P., Heller, J. (1994). 6 Bioabsorbable polymers—in-vitro acute toxicity of accumulated degradation products. J Appl Biomater. 5:151–7.
   PubMedGoogle Scholar
• Tonnesen, H.H., Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm. 28:621–30.
   PubMed Web of Science ®Google Scholar
• Vassileva, V., Grant, J., De Souza, R., Allen, C., Piquette-Miller, M. (2007). Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Cancer Chemother Pharmacol. 60:907–14.
   PubMed Web of Science ®Google Scholar
• Wallace, D.G., Rosenblatt, J. (2003). Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev. 55:1631–49.
   PubMed Web of Science ®Google Scholar
• Wang, P.P., Frazier, J., Brem, H. (2002). Local drug delivery to the brain. Adv Drug Deliv Rev. 54:987–1013.
   PubMed Web of Science ®Google Scholar
• Weinberg, B.D., Ai, H., Blanco, E., Anderson, J.M., Gao, J.M. (2007). Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res Part A. 81A:161–70.
   Google Scholar
• Westphal, M., Hilt, D.C., Bortey, E., Delavault, P., Olivares, R., Warnke,P.C., Whittle, I.R., Jaaskelainen, J., Ram, Z. (2003). A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology. 5:79–88.
   PubMed Web of Science ®Google Scholar
• Yadav, A.K., Mishra, P., Agrawal, G.P. (2008). An insight on hyaluronic acid in drug targeting and drug delivery. J Drug Target. 16:91–107.
   PubMed Web of Science ®Google Scholar
• Ye, S.-F., Hou, Z.-Q., Zhou, Z.-M., Zhong, L.-M., Zhang, Q.-Q. (2008). Intratumoral chemotherapy with an implantable collagen film impregnated with epirubicin-loaded polylactic acid microspheres inhibits tumor growth in hepatocellular carcinoma xenografts. Chin J Biochem Eng. 27:590–6.
   Google Scholar
• Zahedi, P., De Souza, R., Piquette-Miller, M., Allen, C. (2009). Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity. Int J Pharm.
   PubMedGoogle Scholar
• Zheng, J.P., Wang, C.Z., Wang, X.X., Wang, H.Y., Zhuang, H., De Yao, K. (2007). Preparation of biornimetic three-dimensional gelatin/montmorillonite-chitosan scaffold for tissue engineering. React Funct Polym. 67:780–8.
   Web of Science ®Google Scholar